Drug Profile
P 7435
Alternative Names: P-7435; P7435-DGAT1Latest Information Update: 28 Jul 2018
Price :
$50
*
At a glance
- Originator Piramal Life Sciences
- Developer Piramal Enterprises
- Class Antihyperglycaemics; Antihyperlipidaemics; Small molecules
- Mechanism of Action Diacylglycerol O acyltransferase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes - Diabetes mellitus; Lipid metabolism disorders
Highest Development Phases
- No development reported Diabetes mellitus; Lipid metabolism disorders
Most Recent Events
- 28 Jul 2018 No recent reports of development identified for phase-I development in Diabetes-mellitus(In volunteers) in USA (PO, Capsule)
- 28 Jul 2018 No recent reports of development identified for phase-I development in Lipid-metabolism-disorders(In volunteers) in USA (PO, Capsule)
- 16 Jul 2016 No recent reports of development identified for phase-I development in Diabetes-mellitus(In volunteers) in India (PO, Tablet)